Nikkiso Logo - blue_CMYK_transp_bar_ends - cropped - REDONE.jpg
Nikkiso Cryogenic Industries Group Expands in Russia and Wins Project for LNG Liquefaction Terminal
August 05, 2020 03:00 ET | Cryogenic Industries
TEMECULA, Calif., Aug. 05, 2020 (GLOBE NEWSWIRE) -- Nikkiso Cryogenic Industries’ Clean Energy & Industrial Gases Group (“Group”), a subsidiary of Nikkiso Co., Ltd (Japan), announces the...
CryptoCurrencyWire.jpg
CryptoCurrencyWire Announces Collaboration with Blockchain Life 2019 as the Official Newswire
September 23, 2019 09:35 ET | CryptoCurrencyWire
MOSCOW, Sept. 23, 2019 (GLOBE NEWSWIRE) -- via CryptoCurrencyWire – CryptoCurrencyWire (“CCW”), a multifaceted financial news and publishing company,  announces its partnership with Blockchain Life...
Vantage LED Salesman Rows for Team USA
September 21, 2016 11:00 ET | Vantage LED
ATLANTA, GA--(Marketwired - September 21, 2016) - With over fifteen years of international sales and marketing experience, David Bittenbender has been an integral leader of the Vantage LED sales force...
Rafarma Pharmaceuticals, Inc. logo
Rafarma Pharmaceuticals (RAFA) Announces New President as Part of Pending Acquisition of Majority Interest
July 30, 2014 14:40 ET | Rafarma Pharmaceuticals, Inc.
MOSCOW, July 30, 2014 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals Inc. (Pink Sheets:RAFA) announces the appointment of Mr. Bruno Horn, a Swiss citizen, as the new President and Director of the...
Rafarma Pharmaceuticals, Inc. logo
Rafarma Pharmaceuticals (RAFA) Commences Preparation of Audited Financials
May 12, 2014 09:15 ET | Rafarma Pharmaceuticals, Inc.
MOSCOW, May 12, 2014 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. (Pink Sheets:RAFA) has commenced a formal audit to provide additional transparency in its public filings with a forward view to...
Rafarma Pharmaceuticals, Inc. logo
Rafarma (RAFA) Enters $50,000,000 Ceftriaxone Market and Signs Long-Term National and Regional Distribution Contracts
June 06, 2013 09:18 ET | Rafarma Pharmaceuticals, Inc.
SANDY, Utah, June 6, 2013 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. (the "Company") (Pink Sheets:RAFA) announces commencement of production of the antibiotic Ceftriaxone. Ceftriaxone treats...